Using the latest gene sequencing tools to examine so-called epigenetic influences on the DNA makeup of colon cancer, a Johns Hopkins team says its results suggest cancer treatment might eventually be more tolerable and successful if therapies could focus on helping cancer cells get back to normal in addition to strategies for killing them...
New Gene Therapy Corrects Hemophilia In Mice By Precise Repair Of DNA
6/27/2011
A new type of gene therapy reduced blood clotting times to nearly normal levels in live mice with hemophilia. Described as the next step in gene therapy, "genome editing" precisely targets and corrects mutated DNA...
Post-Surgery Organ Damage May Be Caused By Rogue Blood Cells
6/27/2011
A study from scientists at Queen Mary, University of London, sheds new light on why people who experience serious trauma or go through major surgery, can suffer organ damage in parts of the body which are seemingly unconnected to the injury...
Genome Editing, A Next Step In Genetic Therapy, Corrects Hemophilia In Animals
6/27/2011
Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated the blood clotting disorder hemophilia in mice. This is the first time that genome editing, which precisely targets and repairs a genetic defect, has been done in a living animal and achieved clinically meaningful results...
Many Advanced Breast Cancer Patients Do Not Receive Recommended Treatment
6/27/2011
Radiation after a mastectomy for women with advanced breast cancer saves lives, but almost half of these patients do not receive it. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society...
New Computational Tool For Rapid Identification Of Disease-Causing Variations In The Human Genome
6/26/2011
Scientists from the University of Utah and Omicia, Inc., a privately held company developing tools to interpret personal genome sequences, have announced the publication in Genome Research of a new software tool called VAAST, the Variant Annotation, Analysis and Selection Tool, a probabilistic disease-causing mutation finder for individual human genomes...
Stanmore Receives US FDA Approval For Its JTS Non-Invasive Extendible Implant
6/26/2011
Stanmore Implants ("Stanmore"), specialists in the design and manufacture of patient specific implants for complex orthopaedic reconstructions, announces that it has received US FDA 510k approval for its Juvenile Tumour System ("JTS") non-invasive extendible distal femoral replacement ("JTS implant"), for use in paediatric orthopaedic oncology surgery...
Lower Dosages For Anemia Drugs For Patients With Chronic Kidney Disease, FDA
6/25/2011
In a move to address the risk of cardiovascular events linked to Erythropoiesis-Stimulating Agents (ESAs) used in anemia treatment for patients with chronic kidney disease, the FDA (Food and Drug Administration) is recommending lower dosing guidelines. Cardiovascular events include thrombosis, stroke, and even death...
Lower Dosages For Anemia Drugs For Patients With Chronic Kidney Disease, FDA
6/24/2011
In a move to address the risk of cardiovascular events linked to Erythropoiesis-Stimulating Agents (ESAs) used in anemia treatment for patients with chronic kidney disease, the FDA (Food and Drug Administration) is recommending lower dosing guidelines. Cardiovascular events include thrombosis, stroke, and even death...
Astronomers Reach For The Stars To Discover New Cancer Therapy
6/24/2011
Astronomers' research on celestial bodies may have an impact on the human body. Ohio State University astronomers are working with medical physicists and radiation oncologists to develop a potential new radiation treatment - one that is intended to be tougher on tumors, but gentler on healthy tissue...